Iterum Therapeutics plc (ITRMF) Debt Ratio (2018 - 2024)
Iterum Therapeutics (ITRMF) posted quarterly Debt Ratio of 0.32 for Q4 2024, down 25.64% year-over-year from 0.44 in Q1 2024, and down 62.33% quarter-over-quarter from 0.86 in Q3 2024.
Iterum Therapeutics plc (ITRMF) Debt Ratio (2018 - 2024) Analysis & Trends
Iterum Therapeutics' Debt Ratio history runs 7 years deep, the most recent figure standing at 0.32 for Q4 2024.
- In Q4 2024, Debt Ratio fell 25.64% year-over-year to 0.32; the TTM figure through Dec 2024 stood at 0.32 (down 25.64% YoY), while the FY2024 annual figure was 0.32, down 25.64% from the prior year.
- Debt Ratio for Q4 2024 stood at 0.32, down from 0.86 in the prior quarter.
- The five-year high for Debt Ratio was 1.06 in Q3 2020, with the low at 0.09 in Q1 2022.
- The 5-year median for Debt Ratio is 0.27 (2023), against an average of 0.41.
- The sharpest annual moves came in 2020 and 2021: Debt Ratio surged 323.6% in 2020, then plunged 90.98% in 2021.
- Iterum Therapeutics' Debt Ratio stood at 0.88 in 2020, then tumbled by 89.37% to 0.09 in 2021, then surged by 61.52% to 0.15 in 2022, then soared by 188.78% to 0.44 in 2023, then decreased by 25.64% to 0.32 in 2024.
- Business Quant data shows ITRMF's Debt Ratio at 0.32 in Q4 2024, 0.86 in Q3 2024, and 0.91 in Q2 2024.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 0.32 |
| Sep 30, 2024 | 0.86 |
| Jun 30, 2024 | 0.91 |
| Mar 31, 2024 | 0.62 |
| Dec 31, 2023 | 0.44 |
| Sep 30, 2023 | 0.31 |
| Jun 30, 2023 | 0.23 |
| Mar 31, 2023 | 0.19 |
| Dec 31, 2022 | 0.15 |
| Sep 30, 2022 | 0.13 |
| Jun 30, 2022 | 0.11 |
| Mar 31, 2022 | 0.09 |
| Dec 31, 2021 | 0.09 |
| Sep 30, 2021 | 0.10 |
| Jun 30, 2021 | 0.10 |
| Mar 31, 2021 | 0.11 |
| Dec 31, 2020 | 0.88 |
| Sep 30, 2020 | 1.06 |
| Jun 30, 2020 | 0.85 |
| Mar 31, 2020 | 0.58 |